Log In
Print
BCIQ
Print
Print this Print this
 

SIG990

  Manage Alerts
Collapse Summary General Information
Company Signum Dermalogix Inc.
DescriptionTopical anti-inflammatory small molecule analog of isoprenylcysteine (IPC)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentIND
Standard IndicationRosacea
Indication DetailsTreat rosacea
Regulatory Designation

Partner

Dermata Therapeutics LLC


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today